Heterogeneity of local tissue microenvironment influences differentiation of oligodendroglial progenitors

Folia Neuropathologica

Volumn 51, Issue 2, 2013, Pages 103-110

  Sypecka, Joanna ^a   Sarnowska, Anna ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Astrocytes; Glia; Heterogeneity; Hippocampus; Microenvironment; Oligodendroglial progenitors; Organotypic slices; Spinal cord; Trophic factors

Indexed keywords

MESSENGER RNA;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HIPPOCAMPUS; MICROENVIRONMENT; NERVE CELL DIFFERENTIATION; NONHUMAN; RAT;

EID: 84879817018     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: 10.5114/fn.2013.35952     Document Type: Article

References (57)

1. Almad A, Sahinkaya FR, McTigue DM. Oligodendrocyte fate after spinal cord injury. Neurotherapeutics 2011; 8: 262-273.
2. Banu MA, Alter R, Boockvar JA. Resetting the stem cell clock: impact of the systemic milieu on oligodendrocyte precursor cell differentiation and remyelination. Neurosurgery 2012; 70: N15-17.
3. Blanchard J, Chohan MO, Li B, Liu F, Iqbal K, Grundke-Iqbal I. Beneficial effect of a CNTF tetrapeptide on adult hippocampal neurogenesis, neuronal plasticity, and spatial memory in mice. J Alzheimers Dis 2010; 21: 1185-1195.
4. Cao Q, He Q, Wang Y, Cheng X, Howard RM, Zhang Y, DeVries WH, Shields CB, Magnuson DS, Xu XM, Kim DH, Whittemore SR. Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury. J Neurosci 2010; 24: 2989-3001.
5. Chao MV, Rajagopal R, Lee FS. Neurotrophin signalling in health and disease. Clin Sci (Lond) 2006; 110: 167-173. (Pubitemid 43241478)
6. Dewar D, Underhill SM, Goldberg MP. Oligodendrocytes and ischemic brain injury. J Cerebral Blood Flow & Metabolism 2003; 23: 263-274. (Pubitemid 36312995)
7. Duarte EP, Curcio M, Canzoniero LM, Duarte CB. Neuroprotection by GDNF in the ischemic brain. Growth Factors 2012; 30: 242-257.
8. Fortin D, Rom E, Sun H, Yayon A, Bansal R. Distinct fibroblast growth factor (FGF)/FGF receptor signaling pairs initiate diverse cellular responses in the oligodendrocyte lineage. J Neurosci 2005; 25: 7470-7479. (Pubitemid 41129820)
9. Frontczak-Baniewicz M, Chrapusta SJ, Sulejczak D. Long-term consequences of surgical brain injury - characteristics of the neurovascular unit and formation and demise of the glial scar in a rat model. Folia Neuropathol 2011; 49: 204-218.
10. Gonzalez-Perez O, Alvarez-Buylla A. Oligodendrogenesis in the subventricular zone and the role of epidermal growth factor. Brain Res Rev 2011; 67: 147-156.
11. Gójska-Grymajło A, Nyka WM, Zieliński M, Jakubowski Z. CD34/ CXCR4 stem cell dynamics in acute stroke patients. Folia Neuro - pathol 2012; 50: 140-146.
12. Gornicka-Pawlak el B, Janowski M, Habich A, Jablonska A, Drela K, Kozlowska H, Lukomska B, Sypecka J, Domanska-Janik K. Systemic treatment of focal brain injury in the rat by human umbilical cord blood cells being at different level of neural commitment. Acta Neurobiol Exp (Wars) 2011; 71: 46-64.
13. Harvey AR, Ooi JW, Rodger J. Neurotrophic factors and the regeneration of adult retinal ganglion cell axons. Int Rev Neurobiol 2012; 106: 1-33.
14. Hu JG, Zhang YX, Qi Q, Wang R, Shen L, Zhang C, Xi J, Zhou JS, Lu HZ. Expression of BMP-2 and BMP-4 proteins by type-1 and type-2 astrocytes induced from neural stem cells under different differentiation conditions. Acta Neurobiol Exp (Wars) 2012; 72: 95-101.
15. Huyghe A, Horzinski L, Hénaut A, Gaillard M, Bertini E, Schiffmann R, Rodriguez D, Dantal Y, Boespflug-Tanguy O, Fogli A. Deve lopmental splicing deregulation in leukodystrophies related to EIF2B mutations. PLoS One 2012; 7: e38264.
16. Ishii A, Furusho M, Bansal R.Sustained Activation of ERK1/2 MAPK in Oligodendrocytes and Schwann Cells Enhances Myelin Growth and Stimulates Oligodendrocyte Progenitor Expansion. J Neurosci 2013; 33: 175-186.
17. Karimi-Abdolrezaee S, Schut D, Wang J, Fehlings MG. Chondro itinase and growth factors enhance activation and oligodendrocyte differentiation of endogenous neural precursor cells after spinal cord injury. PLoS One 2012; 7: e37589
18. Kim H, Cooke MJ, Shoichet MS. Creating permissive microenvironments for stem cell transplantation into the central nervous system. Trends Biotechnol 2012; 30: 55-63.
19. Sypecka J, Sarnowska A, Gadomska-Szabłowska I, Lukomska B, Domanska-Janik K. Differentiation of glia-committed NG2 cells: the role of factors released from hippocampus and spinal cord. Acta Neurobiologiae Experimentalis (Wars) 2013; 73 [Epub ahead of print].
20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408. (Pubitemid 34164012)
21. Lü HZ, Wang YX, Zou J, Li Y, Fu SL, Jin JQ, Hu JG, Lu PH. Differentiation of neural precursor cell-derived oligodendrocyte progenitor cells following transplantation into normal and injured spinal cords. Differentiation 2010; 80: 228-240.
22. Markiewicz I, Sypecka J, Domanska-Janik K, Wyszomirski T, Lu komska B. Cellular environment directs differentiation of human umbilical cord blood-derived neural stem cells in vitro. J Histochem Cytochem 2011; 59: 289-301.
23. Matsumoto Y, Tsunekawa Y, Nomura T, Suto F, Matsumata M, Tsuchiya S, Osumi N. Differential proliferation rhythm of neural progenitor and oligodendrocyte precursor cells in the young adult hippocampus. PLoS One 2011; 6: e27628.
24. McCarthy KD. de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 1980; 85: 890-902.
25. Mi S, Miller RH, Tang W, Lee X, Hu B, Wu W, Zhang Y, Shields CB, Zhang Y, Miklasz S, Shea D, Mason J, Franklin RJ, Ji B, Shao Z Chédotal A, Bernard F, Roulois A, Xu J, Jung V, Pepinsky B. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann Neurol 2009; 65: 304-315.
26. Miller FD, Gauthier AS. Timing is everything: making neurons versus glia in the developing cortex. Neuron 2007; 54: 357-369. (Pubitemid 46659814)
27. Müller S, Chakrapani BP, Schwegler H, Hofmann HD, Kirsch M. Neurogenesis in the dentate gyrus depends on ciliary neurotrophic factor and signal transducer and activator of transcription 3 signaling. Stem Cells 2009; 27: 431-441.
28. Nait-Oumesmar B, Picard-Riéra N, Kerninon C, Baron-Van Evercooren A. The role of SVZ-derived neural precursors in demyelinating diseases: from animal models to multiple sclerosis. J Neurol Sci 2008; 265: 26-31.
29. Naganska E, Matyja E. Amyotrophic lateral sclerosis - looking for pathogenesis and effective therapy. Folia Neuropathol 2011; 49: 1-13.
30. Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P. Pla teletderived growth factor promotes division and motility and in hibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 1988; 333: 560-562.
31. Raff MC, Miller RH, Noble M. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 1983; 303: 390-396. (Pubitemid 13094875)
32. Robel S, Berninge B, Götz M. The stem cell potential of glia: lessons from reactive gliosis. Nature Reviews Neuroscience 201; 12: 88-104.
33. Rompani SB, Cepko CL. A common progenitor for retinal astrocytes and oligodendrocytes. J Neurosci. 2010; 30: 4970-4980.
34. Rosenberg SS, Kelland EE, Tokar E, De la Torre AR, Chan Jr. The geometric and spatial constraints of the microenvironment induce oligodendrocyte differentiation. Proc Natl Acad Sci U S A 2008; 105: 14662-14667.
35. Reuss B, von Bohlen und Halbach O. Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res 2003; 313: 139-157. (Pubitemid 37129946)
36. Rowitch DH, Kriegstein AR. Developmental genetics of vertebrate glial-cell specification. Nature 2010; 468: 214-222.
37. Sabo JK, Cate HS. Signalling pathways that inhibit the capacity of precursor cells for myelin repair. Int J Mol Sci 2013; 4: 1031-1049.
38. Sarnowska A, Braun H, Sauerzweig S, Reymann KG. The neuroprotective effect of bone marrow stem cells is not dependent on direct cell contact with hypoxic injured tissue. Exp Neurol 2009; 215: 317-327.
39. Saulsbury MD, Heyliger SO, Wang K, Johnson DJ. Chlorpyrifos in - duces oxidative stress in oligodendrocyte progenitor cells. Toxi cology 2009; 259: 1-9.
40. Sim FJ, Windrem MS, Goldman SA. Fate determination of adult human glial progenitor cells. Neuron Glia Biol 2009; 5: 45-55.
41. Son JL, Soto I, Oglesby E, Lopez-Roca T, Pease ME, Quigley HA, Marsh-Armstrong N. Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss. Glia 2010; 58: 780-789.
42. Stoppini L, Buchs PA, Muller D. A simple method for organoty pic cultures of nervous tissue. J Neurosci Methods 1991; 37: 173-182.
43. Sypecka J. Searching for oligodendrocyte precursors for cell replacement therapies. Acta Neurobiol Exp (Wars) 2011; 71: 94-102.
44. Sypecka J, Domańska-Janik K. Phenotypic diversity resulting from a point mutation. Folia Neuropathol 2006; 44: 244-250.
45. Sypecka J, Sarnowska A, Domanska-Janik K. Crucial role of the local micro-environment in fate decision of neonatal rat NG2 progenitors. Cell Prolif 2009; 42: 661-671.
46. Tamura Y, Kataoka Y, Cui Y, Takamori Y, Watanabe Y, Yamada H. Multi-directional differentiation of doublecortin- and NG2- immunopositive progenitor cells in the adult rat neocortex in vivo. Eur J Neurosci 2007; 25: 3489-3498. (Pubitemid 47020456)
47. Tanner DC, Cherry JD, Mayer-Pröschel M. Oligodendrocyte progenitors reversibly exit the cell cycle and give rise to astrocytes in response to interferon-γ. J Neurosci 2011; 31: 6235-6246.
48. Tep C, Lim TH, Ko PO, Getahun S, Ryu JC, Goettl VM, Massa SM, Basso M, Longo FM, Yoon SO. Oral Administration of a Small Molecule Targeted to Block proNGF Binding to p75 Promotes Myelin Sparing and Functional Recovery after Spinal Cord Injury. J Neurosci 2013; 33: 397-410.
49. Volpe JJ, Kinney HC, Jensen FE, Rosenberg PA. The developing oligodendrocyte: key cellular target in brain injury in the premature infant. Int J Dev Neurosci 2011; 29: 423-440.
50. Wang Y, Cheng X, He Q, Zheng Y, Kim DH, Whittemore SR, Cao QL. Astrocytes from the contused spinal cord inhibit oligodendrocyte differentiation of adult oligodendrocyte precursor cells by in creasing the expression of bone morphogenetic proteins. J Neurosci 2011; 31: 6053-6058.
51. Watson RA, Yeung TM. What is the potential of oligodendrocyte progenitor cells to successfully treat human spinal cord injury? BMC Neurol 2011; 11: 113.
52. Wegner M. A matter of identity: transcriptional control in oligodendrocytes. J Mol Neurosci 2008; 35: 3-12.
53. Zaheer S, Thangavel R, Wu Y, Khan MM, Kempuraj D, Zaheer A. Enhanced expression of glia maturation factor correlates with glial activation in the brain of triple transgenic Alzheimer's disease mice. Neurochem Res 2013; 38: 218-225.
54. Zdaniuk G, Wierzba-Bobrowicz T, Szpak GM, Stepień T. Astroglia disturbances during development of the central nervous system in fetuses with Down's syndrome. Folia Neuropathol 2011; 49: 109-114.
55. Zhang L, Ma Z, Smith GM, Wen X, Pressman Y, Wood PM, Xu XM. GDNF-enhanced axonal regeneration and myelination following spinal cord injury is mediated by primary effects on neurons. Glia 2009; 57: 1178-1191.
56. Zhu X, Hill RA, Nishiyama A. NG2 cells generate oligodendrocytes and gray matter astrocytes in the spinal cord. Neuron Glia Biol 2008; 4: 19-26.
57. Zuo T, Qin JY, Chen J, Shi Z, Liu M, Gao X, Gao D. Involvement of N-cadherin in the protective effect of glial cell line-derived neurotrophic factor on dopaminergic neuron damage. Int J Mol Med 2013; doi: 10.3892/ijmm.2013.1226.